CIK: 1219864 - Address: 700 Quince Orchard Road, Gaithersburg, MD 20878
26 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

P%ret1141013164111531
P%wins757550505010067
S%ret11252-57-14-34-7
S%wins505050010010058

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

6/14/24 16:01
6/12/24
NVAXNovavax IncDEHealthBioPrdBiological Products, (No DiagYoung James FMDDM.d00.00071077D
6/13/23 16:49
6/10/23
NVAXNovavax IncDEHealthBioPrdBiological Products, (No DiagYoung James FMDDM.d00.0005770D
6/21/22 20:50
6/17/22
NVAXNovavax IncDEHealthBioPrdBiological Products, (No DiagYoung James FMDDM.d00.0001265D
4/4/22 17:14
3/31/22
NVAXNovavax IncDEHealthBioPrdBiological Products, (No DiagYoung James FMDDS-92073.580-13-1664D
1/4/22 17:04
12/31/21
NVAXNovavax IncDEHealthBioPrdBiological Products, (No DiagYoung James FMDDM.d9625.6004577D
1/4/22 17:04
12/31/21
NVAXNovavax IncDEHealthBioPrdBiological Products, (No DiagYoung James FMDDS.d-541144.160-4-577D
7/6/21 17:06
7/1/21
NVAXNovavax IncDEHealthBioPrdBiological Products, (No DiagYoung James FMDDM.d00.000101577D
6/29/21 17:11
6/25/21
NVAXNovavax IncDEHealthBioPrdBiological Products, (No DiagYoung James FMDDM.d00.00081367D
3/25/21 18:41
3/23/21
NVAXNovavax IncDEHealthBioPrdBiological Products, (No DiagYoung James FMDDM.dm88515.40058999%59D
3/25/21 18:41
3/23/21
NVAXNovavax IncDEHealthBioPrdBiological Products, (No DiagYoung James FMDDS.d-2,282228.220-10-1459D
1/5/21 17:38
12/31/20
NVAXNovavax IncDEHealthBioPrdBiological Products, (No DiagYoung James FMDDM.dm56426.8602112D
1/5/21 17:38
12/31/20
NVAXNovavax IncDEHealthBioPrdBiological Products, (No DiagYoung James FMDDS.d-1,244113.090-11-4912D
6/5/20 17:04
6/3/20
NVAXNovavax IncDEHealthBioPrdBiological Products, (No DiagYoung James FMDDP7348.8302New2I
9/1/17 16:27
8/31/17
NVAXNovavax IncDEHealthBioPrdBiological Products, (No DiagYoung James FMDDS-1851.060-175-1000D
3/16/17 16:19
3/14/17
NVAXNovavax IncDEHealthBioPrdBiological Products, (No DiagYoung James FMDDS-1391.3912-100-36175D-85-72-83371-5-5-3-10-35
6/22/15 17:02
6/18/15
NVAXNovavax IncDEHealthBioPrdBiological Products, (No DiagYoung James FMDDS-4749.4726-50-12375D3969459-2145441213257-14-34
3/25/14 17:48
3/25/14
NVAXNovavax IncDEHealthBioPrdBiological Products, (No DiagYoung James FMDDP1124.4733256425D2159132-12-29-35-24-20-21-710-4116
6/10/13 09:03
6/6/13
NVAXNovavax IncDEHealthBioPrdBiological Products, (No DiagYoung James FMDDP1911.91310033400D-13533-8-24-6-65313672115133
3/12/13 13:45
3/11/13
NVAXNovavax IncDEHealthBioPrdBiological Products, (No DiagYoung James FMDDP2032.03110050300D-206341514813120331-663186
12/6/11 09:36
12/1/11
NVAXNovavax IncDEHealthBioPrdBiological Products, (No DiagYoung James FMDDP2921.46120083440D-55-35-33-17-13-11763-4-8-14-1223
11/16/06 17:54
2/3/06
MEDIMedimmune Inc /deDEHealthBioPrdBiological Products, (No DiagYoung James FMDOP,R,DM.adm342.6501313110D
11/16/06 17:54
2/3/06
MEDIMedimmune Inc /deDEHealthBioPrdBiological Products, (No DiagYoung James FMDOP,R,DS.adm-42132.450-13-11110D
2/7/06 19:22
2/3/06
MEDIMedimmune Inc /deDEHealthBioPrdBiological Products, (No DiagYoung James FMDOP,R,DM.d242.7509New9
2/7/06 19:22
2/3/06
MEDIMedimmune Inc /deDEHealthBioPrdBiological Products, (No DiagYoung James FMDOP,R,DS.d-28232.620-9-509
10/12/05 14:23
9/23/05
MEDIMedimmune Inc /deDEHealthBioPrdBiological Products, (No DiagYoung James FMDOP,R,DM.ad3005.04059117110D
9/27/05 17:00
9/23/05
MEDIMedimmune Inc /deDEHealthBioPrdBiological Products, (No DiagYoung James FMDOP,ResearM.d3005.040590D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact